Skip to content
J

Joel Chekwube Ugwuezea

Publications (3)

Prevalence and Molecular Characterization of Colistin Resistance in Gram-negative Bacteria from Nigeria Hospitals: A Scoping Review

Samuel Chukwuemeka Okenwa, Joel Chekwube Ugwuezea, Chika Augusta Ekweozor, Ifunanya Genevieve Anunwa, Jane Chidera Nwachukwu, Favour Mmesoma Nwankwo, Chukwudi Joseph Alex, Chidimma Elizabeth Mbakamma, Ebere Edith Onyishi, Ifeanyi Joseph Obiekwe & Joy Ulonwadi Ajuonu · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2024

Antibiotic resistance over the years, has emerged as a significant global public health problem, driven by the speedy adaptation of microorganisms to commonly prescribed antibiotics. Colistin, previously regarded as a last-resort antibiotic for treating infections caused by Gram-...

Open access Research Article 10.9734/ajrimps/2024/v13i4281

Barriers to Accessing Affordable Anticancer Medications in Nigeria: A Patient-Centric Perspective

Ebiaye Bethel Temedie, Akosua Dufie Amofah, Samuel Chukwuemeka Okenwa, Jane Chidera Nwachukwu, Joel Chekwube Ugwuezea, Chukwudi Joseph Alex, Chidozie Valentine Akwiwu-Uzoma, Stephen I. Okogu, Favour Mmesoma Nwankwo & Vivian Onyinyechi Sunday · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2024

Background: Limitations to accessing affordable medications for cancer patients in Nigeria is increasing on a daily basis. Several government interventions have been established to address the affordability of drugs for patients at treatment centers. However, they haven’t been co...

Open access Research Article 10.9734/ajrimps/2024/v13i4285

Enhancing Cancer Care in Nigeria: Addressing Gaps and Opportunities in Teaching Hospitals

Samuel Chukwuemeka Okenwa, Lazarus Chukwuemeka Ejike, Ifunanya Genevieve Anunwa, Jane Chidera Nwachukwu, Wisdom Joe Igbokwe, Henry Chiagozie Igwenagu, Emmanuel Buchi Onyioha, Joel Chekwube Ugwuezea & Chika Augusta Ekweozor · International Research Journal of Oncology · 2024

Background: Cancer is currently a global health issue and has claimed the lives of many.  Cancer used to be a previously more prevalent in high-income countries, but at the moment, 75% of new cancer cases could be from low and middle income countries (LMIC). Healthcare workers pl...

Open access Research Article